Undifferentiated Connective Tissue Disease Recruiting Phase Trials for Dalteparin (DB06779)

IndicationStatusPhase
DBCOND0072477 (Undifferentiated Connective Tissue Disease)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03671174Immunosuppressant Regimens for Living Fetuses StudyTreatment